See more : Llorente & Cuenca, S.A. (LLYC.MC) Income Statement Analysis – Financial Results
Complete financial analysis of Genetic Signatures Limited (GSS.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Genetic Signatures Limited, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Automax Motors Ltd (AMX.TA) Income Statement Analysis – Financial Results
- Powersafe Technology Corp. (PSFT) Income Statement Analysis – Financial Results
- Landsea Green Life Service Company Limited (1965.HK) Income Statement Analysis – Financial Results
- Genufood Energy Enzymes Corp. (GFOO) Income Statement Analysis – Financial Results
- Suven Pharmaceuticals Limited (SUVENPHAR.NS) Income Statement Analysis – Financial Results
Genetic Signatures Limited (GSS.AX)
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Website: https://www.geneticsignatures.com
About Genetic Signatures Limited
Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in Newtown, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.77M | 16.94M | 35.42M | 28.28M | 11.26M | 7.02M | 4.99M | 4.06M | 3.27M | 1.04M | 1.29M | 256.98K |
| Cost of Revenue | 25.97M | 29.68M | 28.21M | 24.01M | 13.63M | 2.86M | 1.98M | 1.72M | 1.02M | 395.15K | 606.70K | 397.99K |
| Gross Profit | -16.20M | -12.74M | 7.21M | 4.27M | -2.37M | 4.16M | 3.01M | 2.34M | 2.25M | 648.12K | 685.83K | -141.01K |
| Gross Profit Ratio | -165.89% | -75.21% | 20.36% | 15.10% | -21.00% | 59.27% | 60.29% | 57.56% | 68.89% | 62.12% | 53.06% | -54.87% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 15.14M | 1.49M | 564.00K | 399.00K | 443.00K | 432.00K | 493.52K | 385.31K | 461.25K | 2.37M | 376.62K | 201.12K |
| Selling & Marketing | 0.00 | 1.28M | 1.52M | 1.32M | 566.00K | 5.28M | 4.31M | 3.53M | 3.75M | 0.00 | 1.12M | 1.44M |
| SG&A | 15.14M | 6.30M | 4.26M | 2.84M | 2.47M | 5.71M | 4.81M | 3.91M | 4.21M | 2.37M | 1.50M | 1.64M |
| Other Expenses | -10.83M | 152.00K | 10.00K | 129.00K | 2.64M | 2.10M | 2.15M | 1.76M | 1.53M | 406.99K | 0.00 | 0.00 |
| Operating Expenses | 4.31M | 6.15M | 4.25M | 2.71M | 2.47M | 7.82M | 6.49M | 5.26M | 5.37M | 3.75M | 2.14M | 2.11M |
| Cost & Expenses | 31.98M | 35.83M | 32.45M | 26.73M | 16.09M | 10.68M | 8.48M | 6.98M | 6.38M | 4.15M | 2.75M | 2.51M |
| Interest Income | 504.00K | 543.00K | 132.00K | 206.00K | 271.00K | 168.00K | 229.46K | 250.92K | 90.65K | 41.01K | 273.74K | 293.33K |
| Interest Expense | 35.00K | 1.00K | 19.00K | 36.00K | 33.00K | 519.00 | 525.00 | 423.00 | 1.13K | 454.00 | 0.00 | 293.33K |
| Depreciation & Amortization | 2.00M | 1.53M | 1.62M | 1.43M | 883.00K | 470.75K | 631.80K | 478.70K | 399.31K | 205.55K | 103.88K | 56.02K |
| EBITDA | -20.34M | -13.14M | 4.70M | 3.22M | -1.70M | -3.13M | -2.77M | -2.30M | -2.60M | -2.38M | -2.23M | -2.20M |
| EBITDA Ratio | -208.25% | -102.51% | 12.94% | 10.54% | -35.04% | -44.53% | -55.40% | -56.74% | -79.57% | -235.14% | -87.50% | -858.05% |
| Operating Income | -22.33M | -18.89M | 2.97M | 1.56M | -4.83M | -3.60M | -3.40M | -2.78M | -3.00M | -3.11M | -1.23M | -2.26M |
| Operating Income Ratio | -228.68% | -111.52% | 8.38% | 5.50% | -42.88% | -51.24% | -68.05% | -68.52% | -91.80% | -297.78% | -95.54% | -879.85% |
| Total Other Income/Expenses | 479.00K | -3.85M | 31.00K | 199.00K | 190.00K | -2.04M | 144.32K | -1.90M | -28.65K | -73.66K | -493.63K | -282.37K |
| Income Before Tax | -21.85M | -18.47M | 3.06M | 1.76M | -4.64M | -3.49M | -3.25M | -2.67M | -3.03M | -2.66M | -1.73M | -2.54M |
| Income Before Tax Ratio | -223.78% | -109.06% | 8.65% | 6.21% | -41.20% | -49.72% | -65.16% | -65.75% | -92.68% | -254.88% | -133.73% | -989.73% |
| Income Tax Expense | -3.99M | -4.42M | 1.39M | 1.19M | -2.55M | -2.15M | -2.14M | -2.02M | -1.43M | 407.44K | 0.00 | 528.99K |
| Net Income | -17.86M | -14.05M | 3.06M | 1.76M | -2.09M | -3.49M | -3.25M | -2.67M | -3.03M | -2.66M | -1.73M | -2.01M |
| Net Income Ratio | -182.90% | -82.96% | 8.65% | 6.21% | -18.52% | -49.72% | -65.16% | -65.75% | -92.68% | -254.88% | -133.73% | -783.88% |
| EPS | -0.11 | -0.10 | 0.02 | 0.01 | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 | -0.05 | -0.02 | -0.08 |
| EPS Diluted | -0.11 | -0.10 | 0.02 | 0.01 | -0.02 | -0.03 | -0.03 | -0.03 | -0.04 | -0.05 | -0.02 | -0.08 |
| Weighted Avg Shares Out | 165.26M | 146.81M | 146.51M | 146.20M | 129.96M | 106.47M | 103.95M | 96.06M | 71.98M | 50.69M | 70.07M | 25.58M |
| Weighted Avg Shares Out (Dil) | 165.26M | 146.81M | 148.90M | 149.14M | 129.96M | 106.47M | 103.95M | 96.06M | 72.83M | 50.69M | 70.07M | 25.58M |
Source: https://incomestatements.info
Category: Stock Reports